Results for
"[search-keyword]"
Sponsor content
176 result(s) found, displaying 21 to 30
-
Cancellation by sponsorRequested by Eli Lilly Australia Pty Ltd
-
Cancellation by sponsorRequested by Eli Lilly Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMVOH mirikizumab 100 mg/mL solution for injection autoinjector (pre-filled pen).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMVOH mirikizumab 100 mg/mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMVOH mirikizumab 300 mg/15 mL (20 mg/mL) concentrated injection vial for IV infusion.
-
Australian Public Assessment Report (AusPAR)Retevmo (selpercatinib) is provisionally approved for the treatment of adults with locally advanced or metastatic RET fusion positive non-small cell lung cancer.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO tirzepatide 10 mg/0.5 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO tirzepatide 2.5 mg/0.5 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO tirzepatide 5 mg/0.5 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO tirzepatide 7.5 mg/0.5 mL solution for injection vial.